Georgia Tomaras

Georgia Tomaras

Duke University

H-index: 88

North America-United States

About Georgia Tomaras

Georgia Tomaras, With an exceptional h-index of 88 and a recent h-index of 58 (since 2020), a distinguished researcher at Duke University, specializes in the field of host-pathogen interactions, immunology, vaccines.

His recent articles reflect a diverse array of research interests and contributions to the field:

A candidate antibody drug for prevention of malaria

A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals

A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087)

The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy

Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV

Intersectional climate justice, health equity, and HIV

Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without …

Georgia Tomaras Information

University

Position

Professor Depts of Surgery Immunology and Molecular Genetics and Microbiology

Citations(all)

30329

Citations(since 2020)

13164

Cited By

23370

hIndex(all)

88

hIndex(since 2020)

58

i10Index(all)

282

i10Index(since 2020)

235

Email

University Profile Page

Google Scholar

Georgia Tomaras Skills & Research Interests

host-pathogen interactions

immunology

vaccines

Top articles of Georgia Tomaras

A candidate antibody drug for prevention of malaria

Nature Medicine

2024/1/2

A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals

medRxiv

2024

A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087)

medRxiv

2024

The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy

AIDS

2022/4/20

Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV

Pharmaceutics

2024/4/27

Intersectional climate justice, health equity, and HIV

The Lancet HIV

2024/4/3

Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

nature communications

2024/3/22

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without …

Plos Medicine

2024/3/19

Tailoring Tfh profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques

Elife

2024/2/22

A tool for analyzing complex epitope binning data of monoclonal antibodies

Biophysical Journal

2024/2/8

Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial

Ebiomedicine

2024/2/1

Defining genetic diversity of rhesus macaque Fcγ receptors with long-read RNA sequencing

Frontiers in Immunology

2024/1/9

Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response

PLoS pathogens

2023/5/31

Oral and intranasal Ad5 influenza vaccination induces hemagglutinin-specific and influenza neutralizing antibodies in serum and milk of pregnant and lactating ferrets

The Journal of Immunology

2023/5/1

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques

Frontiers in Immunology

2023/4/21

Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized …

Vaccine

2023/4/17

Safety and immunogenicity of Ad26-vectored HIV vaccine with mosaic immunogens and a novel mosaic envelope protein in HIV-uninfected adults: a phase 1/2a study

The Journal of Infectious Diseases

2023/4/15

Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants

Journal of Virology

2023/12/21

H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trials

Frontiers in Immunology

2023/4/6

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

Nature Communications

2023/12/14

See List of Professors in Georgia Tomaras University(Duke University)

Co-Authors

academic-engine